Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:bfsLayer |
4
|
| gptkbp:bfsParent |
gptkb:Vii_V_Healthcare
|
| gptkbp:approves |
January 2021
|
| gptkbp:dosage_form |
long-acting injectable
|
| gptkbp:effective_date |
FDA approved
|
| gptkbp:formulation |
injectable
|
| https://www.w3.org/2000/01/rdf-schema#label |
Cabenuva
|
| gptkbp:ingredients |
gptkb:rilpivirine
cabotegravir |
| gptkbp:is_used_for |
treatment of HIV
|
| gptkbp:manager |
intramuscular injection
|
| gptkbp:manufacturer |
gptkb:Vii_V_Healthcare
|